Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Revenue projections:

Revenue projections for MAXHEALTH
Revenue projections for MAXHEALTH

Investors may be wary of MAXHEALTH as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio 0.00000
forwardPE 47.55513
debtToEquity 32.57900
earningsGrowth 0.26600
revenueGrowth 0.10700
grossMargins 0.62012
operatingMargins 0.20656
trailingEps 14.49000
forwardEps 21.01561

With both earnings and revenue growth showing positive trends, MAXHEALTH is expected to expand its business. This signals a healthy financial trajectory, suggesting that the company is positioned for continued growth and increasing profitability.
With positive gross and operating margins, Max Healthcare Institute Limited demonstrates its profitability and efficiency. These metrics show that the company is managing costs well while generating strong revenue, highlighting robust financial health.
MAXHEALTH's forward EPS exceeds its trailing EPS, indicating that the company is projected to be more profitable in the current financial year compared to the previous one. This suggests positive growth and improved earnings, signaling an optimistic outlook for MAXHEALTH's financial performance.

Price projections:

Price projections for MAXHEALTH
Price projections for MAXHEALTH

Over time, price projections for MAXHEALTH have been gradually revised upward, reflecting increasing optimism about the company's future performance. This trend suggests analysts are growing more confident in MAXHEALTH's ability to deliver strong results and achieve higher market value.

Recommendation changes over time:

Recommendations trend for MAXHEALTH
Recommendations trend for MAXHEALTH


MAXHEALTH has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view MAXHEALTH as a reliable choice for their money, offering a promising avenue for future growth and financial gains.